Evaxion A/S
CVR 31762863 · Public limited company (A/S) · Active · Low risk
Evaxion A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 17 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 108.3m and a net result of DKK -51.5m. CEO: Andreas Holm Mattsson, Thomas Frederik Schmidt.
Bankruptcy risk for Evaxion A/S
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 31762863
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (18 years)
- Address
- Dr Neergaards Vej 5F
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 115.3m
- Employees
- 24 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 17 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 60.0% |
| Current ratio | 585% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 34 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 48.1m | DKK 22.3m | DKK 507k |
| Gross profit | DKK 48.1m | DKK 22.3m | DKK 507k |
| Net profit | DKK -51.5m | DKK -73.3m | DKK -152.4m |
| Equity | DKK 108.3m | DKK -11.8m | DKK -31.9m |
| Total assets | DKK 180.5m | DKK 94.7m | DKK 92.5m |
| Cash | DKK 147.6m | DKK 42.3m | – |
| Short-term debt | DKK 27.0m | DKK 36.7m | – |
| Avg. employees | 45 | 46 | – |
Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 110 | ||
| 1 Jan 2024 – 31 Dec 2024 | 121 | ||
| 1 Jan 2023 – 31 Dec 2023 | 109 | ||
| 1 Jan 2022 – 31 Dec 2022 | 158 | ||
| 1 Jan 2021 – 31 Dec 2021 | 143 | ||
| 1 Jan 2020 – 31 Dec 2020 | 155 | ||
| 1 Jan 2019 – 31 Dec 2019 | 182 | ||
| 1 Jan 2018 – 31 Dec 2018 | 94 | ||
| 1 Jan 2017 – 31 Dec 2017 | 160 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 171 | ||
| 1 Jan 2014 – 31 Dec 2014 | 176 | ||
| 1 Jan 2013 – 31 Dec 2013 | 218 | Late | |
| 1 Jan 2012 – 31 Dec 2012 | 179 | ||
| 1 Jan 2011 – 31 Dec 2011 | 179 | ||
| 1 Jan 2010 – 31 Dec 2010 | 179 | ||
| 11 Aug 2008 – 31 Dec 2009 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Andreas Holm Mattsson | Current | |
| CEO | Thomas Frederik Schmidt | Current | |
| CEO | Niels Iversen Møller | ||
| CEO | Bo Løkke Karmark | ||
| CEO | Jesper Nyegaard Nissen | ||
| Board | Roberto Prego Pineda | Current | |
| Board | Marianne Søgaard | Current | |
| Board | Lars Holtug | Current | |
| Board | Lars Aage Staal Wegner | Current | |
| Board | Jens Bitsch-Nørhave | Current | |
| Board | Lars Aage Staal Wegner | ||
| Board | Thomas William Wylonis | ||
| Board | Roberto Prego Novo | ||
| Board | Lars Aage Staal Wegner | ||
| Board | Thomas William Wylonis | ||
| Board | Steven J. Projan | ||
| Board | Jo Ann Suzich | ||
| Board | Kim Bjørnstrup | ||
| Board | Helen Marie Boudreau | ||
| Board | Niels Iversen Møller | ||
| Board | Helen Katrina Tayton-Martin | ||
| Owner (90%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | Current | |
| Owner (20%) | NIMEDICAL HOLDING ApS | ||
| Owner (20%) | MATTSSON HOLDING AF 2008 ApS | ||
| Owner (5%) | Medicina Argos, S.A. | ||
| Owner (5%) | Punga Punga C.V. | ||
| Owner (5%) | Fidaco Investments C.V. | ||
| Owner (15%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (20%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (25%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (15%) | NIMEDICAL HOLDING ApS | ||
| Owner (15%) | MATTSSON HOLDING AF 2008 ApS | ||
| Owner (33%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (50%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (10%) | MATTSSON HOLDING AF 2008 ApS | ||
| Owner (10%) | NIMEDICAL HOLDING ApS | ||
| Owner (33%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (50%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Owner (5%) | NIMEDICAL HOLDING ApS | ||
| Owner (5%) | MATTSSON HOLDING AF 2008 ApS | ||
| Owner (67%) | BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PIVOT REVISION REGISTRERET REVISIONSSELSKAB A/S | ||
| Auditor | GBH REVISION & RÅDGIVNING REGISTRERET REVISIONSAKTIESELSKAB | ||
| Auditor | GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | Christian Schwenn Albrecht Johansen | ||
| Founder | NIMEDICAL HOLDING ApS | Current | |
| Founder | MATTSSON HOLDING AF 2008 ApS | Current |
The CEOs' other companies
Andreas Holm Mattsson – 3 other companies
- CSM COT 10 ApS Active
- MATTSSON HOLDING AF 2008 ApS Active
- MOURIER-GRUPPEN ApS Active
Thomas Frederik Schmidt – 4 other companies
- AMBU A/S Active
- Ambu Nordic A/S Active
- Ambu Operations A/S Active
- Ambu Rusland Holding ApS Opløst
Niels Iversen Møller – 2 other companies
- MEDCONSULT ApS Opløst
- NIMEDICAL HOLDING ApS Active
Bo Løkke Karmark – 4 other companies, of which 1 bankrupt
- AQUAPORIN A/S Bankrupt 2 Feb 2026
- Aquaporin Membrane Proteins ApS Opløst
- BOK Holding A/S Active
- KPT AF 1.1.1999 A/S Fusioneret
Jesper Nyegaard Nissen – 1 other companies
- Nyegaard Consulting ApS Active
Address history (7 moves)
| Dr Neergaards Vej 5F, 2970 Hørsholm | |
| Dr Neergaards Vej 5F, 2970 Hørsholm | |
| Bredgade 34E, 1260 København K | |
| Ole Maaløes Vej 3, 2200 København N | |
| c/o Niels Iveresn Møller, Toldbodgade 38B, st. th, 1253 København K | |
| c/o Niels Iversen Møller, Ferlevej 100, 3250 Gilleleje | |
| Ole Maaløes Vej 3, 2200 København N | |
| c/o Niels Iversen Møller, Ole Suhrs Gade 19, 5. th, 1354 København K |
Former names
| Evaxion A/S | – now |
| EVAXION BIOTECH A/S | – |
| EVAXION BIOTECH ApS | – |
| NOVVAC ApS | – |
Employees per year
Other companies at the same address
- TERMIT ApS Bankrupt
- 3D DERMA HOLDING A/S Opløst
- 3D HOLDING A/S Opløst
- ADRESPONSE NETWORK ApS Fusioneret
- AdResponse Network ApS Opløst
- BB ApS Opløst
- BY ENBOM ApS Active
- DGC Certification ApS Opløst
- DIREKT ApS Fusioneret
- E & S HOLDING ApS Fusioneret
- ENBOM.DK ApS Active
- ENEBORG INVEST ApS Opløst
- ERP-AFDELINGEN ApS Opløst
- HARALD V. LASSEN A/S Active
- HVL FUNDING A/S Active
- INSIDE TECHNOLOGY SALES ApS Opløst
- IT-AFDELINGEN A/S Fusioneret
- IT-GRUPPEN DANMARK ØST A/S Opløst
- JJ X-RAY A/S Active
- JJ X-RAY HOLDING A/S Active
- Jesper Lodahl ApS Active
- KAPOW TECHNOLOGIES R&D ApS Opløst
- KEYSOFT A/S Opløst
- MANNAZ INVEST A/S Fusioneret
- Mannaz Consulting A/S Fusioneret
Similar companies in Rudersdal
- GigaVax ApS Holte
- Migalis ApS Vedbæk
- LIVAG ApS Vedbæk
- CysBio ApS Hørsholm
- Ceremedy ApS Virum
- Cell to Cure ApS Birkerød
- JKastrup.ApS Birkerød
- immunAware ApS Hørsholm
- ASTIM Holding ApS Birkerød
- ASRØ Holding ApS Nærum
- Detalo Instruments Aps Birkerød
- ResoTher Pharma A/S Holte
Questions and answers about Evaxion A/S
Has Evaxion A/S gone bankrupt?
No, Evaxion A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Evaxion A/S?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of Evaxion A/S?
Andreas Holm Mattsson, Thomas Frederik Schmidt are the CEOs of Evaxion A/S.
Who is the auditor of Evaxion A/S?
Evaxion A/S most recently used EY Godkendt Revisionspartnerselskab.
When was Evaxion A/S founded?
Evaxion A/S was founded on 11 August 2008.
What is the equity of Evaxion A/S?
Equity was DKK 108.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.